MIAT and cardiac hypertrophy: In addition, lncRNA MIAT is significantly increased in Ang II-induced cardiac hypertrophy and contributes to the pathological development by suppressing miR-150 expression in cardiomyocytes; moreover, miR-150 is a downstream effector of MIAT in the development of cardiac hypertrophy (50).